# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-26-011941
Filing Date
2026-02-26
Accepted
2026-02-26 06:04:15
Documents
14
Period of Report
2026-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | bgne-20260226.htm iXBRL | 8-K | 33878
2 | EX-99.1 | exhibit991-q42025earningsr.htm | EX-99.1 | 449598
6 |  | bgi2404beoneprimarylogorgba.jpg | GRAPHIC | 1350567
| Complete submission text file | 0001628280-26-011941.txt |  | 2491810

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bgne-20260226.xsd | EX-101.SCH | 1867
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bgne-20260226_lab.xml | EX-101.LAB | 22720
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bgne-20260226_pre.xml | EX-101.PRE | 13107
16 | EXTRACTED XBRL INSTANCE DOCUMENT | bgne-20260226_htm.xml | XML | 2863

Mailing Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051
Business Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051 41-616851900
BeOne Medicines Ltd. (Filer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 26681459
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)